One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 12, 2000, Pages 1605-1611

  Veldhuyzen Van Zanten, S ^{a,b,c,d,e,f,g,h,i,j,k,l}   Lauritsen, K ^{a,b,c,d,e,f,g,h,i,j,k}   Delchier, J C ^{a,b,c,d,e,f,g,h,i,j,k}   Labenz, J ^{a,b,c,d,e,f,g,h,i,j,k}   De Argila, C M ^{a,b,c,d,e,f,g,h,i,j,k}   Lind, T ^{a,b,c,d,e,f,g,h,i,j,k}   Treichel, H C ^{a,b,c,d,e,f,g,h,i,j,k}   Stubberod A ^{a,b,c,d,e,f,g,h,i,j,k}   Cockeram, A ^{a,b,c,d,e,f,g,h,i,j,k}   Hasselgren, G ^{a,b,c,d,e,f,g,h,i,j,k}   Gothe L ^{a,b,c,d,e,f,g,h,i,j,k}   Wrangstadh, M ^{a,b,c,d,e,f,g,h,i,j,k}   Sinclair, P ^{a,b,c,d,e,f,g,h,i,j,k}  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c HENRI MONDOR HOSPITAL   (France)

^d Ev Jung Stilling Krankenhaus   (Germany)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f Karnsjukhuset   (Sweden)

^g Johanniter Krankenhaus   (Germany)

^h Varnamo Hospital   (Sweden)

ⁱ SAINT JOHN REGIONAL HOSPITAL   (Canada)

^j ASTRAZENECA R AND D   (Sweden)

^k ASTRAZENECA   (United Kingdom)

^l DALHOUSIE UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AMOXICILLIN; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DUODENAL ULCER; ENZYME INHIBITORS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; STEREOISOMERISM;

EID: 17744365960     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00911.x     Document Type: Article

References (17)

1. Helicobacter pylori
2. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report
3. Consensus Conference participants. Canadian Helicobacter pylori consensus conference
4. Canadian Helicobacter pylori consensus conference update: Infections in adults
5. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease
6. Medical treatment of peptic ulcer disease. Practice guidelines
7. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials - The MACH 1 study
8. The MACH 2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
9. The GU-MACH study: The effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer
10. The DU-MACH study: Eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole-based triple therapy
11. Esomeprazole provides improved acid control versus omeprazole in patients with symptoms of gastro-oesophageal reflux disease
12. Pharmacokinetics and dose-response relationship of esomeprazole
13. Guidelines for clinical trials in Helicobacter pylori infection
14. Resistance of Helicobacter pylori to antibiotics: The main limitation of current proton pump inhibitor therapy
15. H. pylori resistance to metronidazole and clarithromycin: Effect on the outcome of eradication therapy
16. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
17. The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia